ALAMEDA, Calif., June 7, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO Kenneth Chahine will present information on Avigen’s 2007 development programs and product pipeline at the Needham and Company Sixth Annual Biotechnology & Medical Technology Conference. Dr. Chahine will present on Thursday, June 14, 2007, from 10:30 to 11:00 a.m. EDT at the New York Palace Hotel.
